Meropenem Injection IP 1g Seized Worth Rs 5.88 Lakhs For DPCO Violations

Mancherial: Today, Under the supervision of M. SrinivasuIu, AD, Karimnagar I, T.Chandana Drugs Inspector, Mancherial,  seized 118×1 gm vials of Asmero 1gm*(Meropenem Injection IP 1g) B.No: CI22159H, M/d: 09/2022,  E/D:  08/2024, Mfd. by: Curehealth pharmaceuticals Pvt Ltd, Vill. Raipur, P.O. Deothi, Tehsil & Dist. Solan, H.P and  Marketed by: Astam Healthcare Pvt Ltd, Vill. Theda, Teh. Nalagarh, Dist. Solan, H.P for the violation of  Para 13, 14(1) & (2) & 24 of DPCO 2013 r/w 1579(E) dated 31.03.2023.

Prices of 27 formulations were revised vide SO 1579(E) dtd 31.3.2023 with respect to WPI @12.1218%. Ceiling Price of Meropenem Injection IP 1g was originally fixed under NLEM, 2022. Ceiling price of this formulation is revised including WPI : Rs 952.68  for 1g vial on 31.3.2023.

Asmero1gm 1 is found printed with MRP on the label: Rs. 4200/- for 1g vial.

Ceiling price + GST(12%) is worked out to be  Rs 1067 per 1g vial.

As per DCOs, the formulation is printed with Excess : Rs. 3133/- per 1g vial.

Therefore, 1g vial is charged excess of  Rs 3133/- i.e., 293 % Excess MRP.  Total Worth of seized formulation is Rs.5,88,000/-

Related Posts

  • Pharma
  • March 13, 2025
  • 82 views
Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma

A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash from the industry’s most influential lobby group, as India moves…

  • Pharma
  • March 13, 2025
  • 74 views
Indian Pharma market to expand by 8-9 percent in FY 26: Report

New Delhi: Indian pharmaceutical market is projected to see a growth of 8-9 per cent year-on-year in FY26 as per the recent report by India Ratings and Research (Ind-Ra). The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma

Indian generic drugs linked to deaths in US? Trade group slams study blaming desi pharma

Indian Pharma market to expand by 8-9 percent in FY 26: Report

Indian Pharma market to expand by 8-9 percent in FY 26: Report

India’s Pharma Exports Face Tariff Hurdle amidst Trade Talks with the U.S.

India’s Pharma Exports Face Tariff Hurdle amidst Trade Talks with the U.S.

ED arrests two for trafficking banned drugs to US citizens

ED arrests two for trafficking banned drugs to US citizens